Literature DB >> 11607836

14-3-3 proteins; bringing new definitions to scaffolding.

G Tzivion1, Y H Shen, J Zhu.   

Abstract

The 14-3-3 proteins are a part of an emerging family of proteins and protein domains that bind to serine/threonine-phosphorylated residues in a context specific manner, analogous to the Src homology 2 (SH2) and phospho-tyrosine binding (PTB) domains. 14-3-3 proteins bind and regulate key proteins involved in various physiological processes such as intracellular signaling (e.g. Raf, MLK, MEKK, PI-3 kinase, IRS-1), cell cycling (e.g. Cdc25, Wee1, CDK2, centrosome), apoptosis (e.g. BAD, ASK-1) and transcription regulation (e.g. FKHRL1, DAF-16, p53, TAZ, TLX-2, histone deacetylase). In contrast to SH2 and PTB domains, which serve mainly to mediate protein-protein interactions, 14-3-3 proteins in many cases alter the function of the target protein, thus allowing them to serve as direct regulators of their targets. This review focuses on the various mechanisms employed by the 14-3-3 proteins in the regulation of their diverse targets, the structural basis for 14-3-3-target protein interaction with emphasis on the role of 14-3-3 dimerization in target protein binding and regulation and provides an insight on 14-3-3 regulation itself.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11607836     DOI: 10.1038/sj.onc.1204777

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  106 in total

1.  14-3-3 amplifies and prolongs adrenergic stimulation of HERG K+ channel activity.

Authors:  Anna Kagan; Yonathan F Melman; Andrew Krumerman; Thomas V McDonald
Journal:  EMBO J       Date:  2002-04-15       Impact factor: 11.598

2.  Interaction with 14-3-3 proteins promotes functional expression of the potassium channels TASK-1 and TASK-3.

Authors:  Sindhu Rajan; Regina Preisig-Müller; Erhard Wischmeyer; Ralf Nehring; Peter J Hanley; Vijay Renigunta; Boris Musset; Günter Schlichthörl; Christian Derst; Andreas Karschin; Jürgen Daut
Journal:  J Physiol       Date:  2002-11-15       Impact factor: 5.182

Review 3.  The 14-3-3 proteins: gene, gene expression, and function.

Authors:  Yasuo Takahashi
Journal:  Neurochem Res       Date:  2003-08       Impact factor: 3.996

4.  Salmonid genomes have a remarkably expanded akirin family, coexpressed with genes from conserved pathways governing skeletal muscle growth and catabolism.

Authors:  Daniel J Macqueen; Bjarni K Kristjánsson; Ian A Johnston
Journal:  Physiol Genomics       Date:  2010-04-13       Impact factor: 3.107

5.  Differential roles of ATM- and Chk2-mediated phosphorylations of Hdmx in response to DNA damage.

Authors:  Yaron Pereg; Suzanne Lam; Amina Teunisse; Sharon Biton; Erik Meulmeester; Leonid Mittelman; Giacomo Buscemi; Koji Okamoto; Yoichi Taya; Yosef Shiloh; Aart G Jochemsen
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

6.  14-3-3 gamma associates with muscle specific kinase and regulates synaptic gene transcription at vertebrate neuromuscular synapse.

Authors:  Laure Strochlic; Annie Cartaud; Alexandre Mejat; Régis Grailhe; Laurent Schaeffer; Jean-Pierre Changeux; Jean Cartaud
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-16       Impact factor: 11.205

7.  ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage.

Authors:  Lihong Chen; Daniele M Gilkes; Yu Pan; William S Lane; Jiandong Chen
Journal:  EMBO J       Date:  2005-09-15       Impact factor: 11.598

8.  Regulation of p53-MDMX interaction by casein kinase 1 alpha.

Authors:  Lihong Chen; Changgong Li; Yu Pan; Jiandong Chen
Journal:  Mol Cell Biol       Date:  2005-08       Impact factor: 4.272

9.  14-3-3 sigma positively regulates p53 and suppresses tumor growth.

Authors:  Heng-Yin Yang; Yu-Ye Wen; Chih-Hsin Chen; Guillermina Lozano; Mong-Hong Lee
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

10.  14-3-3zeta escorts CCTalpha for calcium-activated nuclear import in lung epithelia.

Authors:  Marianna Agassandian; Bill B Chen; Christopher C Schuster; Jon C D Houtman; Rama K Mallampalli
Journal:  FASEB J       Date:  2009-12-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.